Tharimmune announces $2.08M private placement; 659K shares & warrants at $3.16/unit

Canton Strategic Holdings, Inc.

Gross proceeds of ~$2.08M from sale of 659,545 shares (or equivalents) and warrants to purchase 329,771 shares.
Warrants exercisable at $3.09 per share beginning 6 months after issuance, expiring 5.5 years later.
Closing expected June 21, 2024; led by SDS Capital Group and Gravitas Capital.
Net proceeds to fund clinical development and working capital, including TH104 program.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.